Table 2 Univariate associations with CKD documentation
Baseline Characteristics | With CKD Documentation N = 1478 (14.40) (% or SD) | Without CKD Documentation N = 8788 (85.6) (% or SD) | Odds Ratio (with vs without CKD documentation) | P value |
|---|---|---|---|---|
Mean age (continuous) | 62.84 (13.51) | 63.10 (13.41) | NA | 0.4829 |
Mean eGFR* (continuous) | 38.66 (13.04) | 50.52 (8.41) | NA | < .0001 |
Men | 876 (21.08) | 3279 (78.92) | 2.44 (2.18-2.73) | < .0001 |
Hypertension | 1397 (17.65) | 6519 (82.35) | 6.00 (4.77-7.54) | < .0001 |
Diabetes | 565 (22.53) | 1943 (77.47) | 2.18 (1.94-2.44) | < .0001 |
eGFR 50-59 | 346 (5.90) | 5522 (94.10) | 1.00 (Referent) | - |
eGFR 40-49 | 372 (14.35) | 2221 (85.65) | 2.67 (2.29-3.12) | - |
eGFR 30-49 | 362 (31.70) | 780 (68.30) | 7.40 (6.27-8.73) | - |
eGFR 20-39 | 252 (50.14) | 205 (44.86) | 19.61 (15.84-24.3) | - |
eGFR 10-19 | 146 (70.87) | 60 (29.13) | 38.83 (28.21-53.46) | < 0.0001** |
Coronary artery disease | 293 (21.95) | 1042 (78.05) | 1.83 (1.59-2.12) | < .0001 |
Chronic heart failure | 216 (28.80) | 534 (71.20) | 2.64 (2.23-3.13) | < .0001 |
Cerebrovascular disease | 38 (23.31) | 125 (76.69) | 1.82 (1.26- 2.64) | 0.0011 |
Peripheral artery disease | 151 (30.82) | 339 (69.18) | 2.83 (2.32-3.46) | < .0001 |
ACEI use | 300 (20.00) | 1200 (80.00) | 1.61 (1.39-1.85) | < .0001 |
ARB use | 34 (21.79) | 122 (78.21) | 1.67 (1.13-2.45) | 0.0080 |
Statin use | 248 (17.13) | 1200 (82.87) | 1.27 (1.09- 1.48) | 0.0014 |
NSAID use | 122 (10.06) | 1091 (89.94) | 0.63 (0.52- 0.77) | < .0001 |